Systemic sclerosis and occupational exposure to organic solvents: " Perchlorethylene", A case;Sclérodermie systémique et exposition professionnelle aux solvants organiques « perchloréthylène ». À propos d'un cas

Revue Francaise d'Allergologie

Volumn 50, Issue 6, 2010, Pages 501-508

  Benzarti Mezni, A ^a,b   Ben Amor, A ^b   El Euch, D ^a   Mbazaa, A ^a   Ben Osmen, A ^a   Ben Jemaa A ^a,b  

^a LA RABTA HOSPITAL   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Case report; Exposition professionnelle; Occupational exposure; Perchlorethylene; Scl rodermie; Scleroderma; Solvant; Solvents; Travail

Indexed keywords

ANTINUCLEAR ANTIBODY; ORGANIC SOLVENT; TETRACHLOROETHYLENE;

ADULT; AIR QUALITY; ARTICLE; CASE REPORT; HUMAN; INDUSTRY; LUNG FUNCTION; MALE; METEOROLOGY; OCCUPATIONAL EXPOSURE; SCLERODERMA; SYSTEMIC SCLEROSIS;

EID: 84866562713     PISSN: 18770320     EISSN: 18770312     Source Type: Journal    
DOI: 10.1016/j.reval.2010.01.041     Document Type: Article

References (30)

1. Garnier R., Bazire A., Chataigner D. Sclérodermie et exposition professionnelle aux solvants organiques. Arch Mal Prof 2006, 67:488-504.
2. Magnant J., Diot E. Sclérodermie systémique : épidémiologie et facteurs environnementaux. Presse Med 2006, 35:1894-1901.
3. Birgitta K., Wolfgang U., Hans D. Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma?. Occup Med Toxicol 2006, 1:15.
4. Erasmus L.D. Sleroderma in gold miners on the Witwatersrand with articular reference to pulmonary manifestations. S Afr J Lab Clin Med 1957, 3:209-231.
5. Lauwerys R., Haufroid V., Hoet P., Lison D. Les solvants toxicologie industrielle et intoxications professionnelles 2007, Elsevier Masson, Issy-les-Moulineaux, pp. 1128-43. 5e ed.
6. Kettaneh A., Al Moufi O., Tiev K.P., Chavet C., et al. Occupational exposure to solvents and gender-related risk of systemic sclerosis: a mataanalysis of case-control studies. J Rheum 2007, 34:97-103.
7. Diot E., Lesire V., Guilmot J.L., Metzger M.D., Pilore R., Rogier S., et al. Systemic sclerosis and occupational risk factors: a case-control study. Occup Environ Med 2002, 59:545-549.
8. Walder B. Solvents and scleroderma. Lancet 1965, 2:436-437.
9. Brasington R.D., Thorpe-Swenson A.J. Systemic sclerosis associated with cutaneous exposure to solvent: case report and review of the literature. Arthritis Rheum 1991, 34:631-633.
10. Bottomley W.W., Sheehan-Dare R.A., Hughes P., Cunliffe W.J. A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents. Br J Dermatol 1993, 128:203-206.
11. Rivière-Orset G., Bertrand O., Ulrich G., Pinault A.L., Petiet G. Sclérodermie et exposition professionnelle aux solvants A propos de deux cas. Arch Mal Prof 2003, 64:510-514.
12. Reinl W. Sklerodermie durch Trichloräthylen-Einwirkung. Zentralbl Arbeitsmed Arbeitsschutz 1957, 7:58-60.
13. Czirjak L., Pocs E., Szegedi G. Localised scleroderma after occupational exposure to organic solvent. Dermatology 1994, 189:399-401.
14. Flindt-Hansen H., Isager H. Scleroderma after occupational exposure to trichlorethylene and trichlorethane. Acta Derm Venereol 1987, 67:263-264.
15. Czirjak L., Danko K., Schlammadinger J., Suranyi P., Tamasi L., Szegedi G.Y. Progressive systemic sclerosis occurring in patients exposed to chemicals. Int J Dermatol 1987, 26:374-378.
16. Czirjak L., Szegedi G. Benzene exposure and systemic sclerosis. Ann Intern Med 1987, 107:118.
17. Calvani N., Silvestris F., Dammacco F. Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors. Ann Ital Med Int 2001, 16:175-178.
18. Nietert P.J., Sutherland S.E., Silver R.M., Pandey J.P., Knapp R.G., Hoel D.G., et al. Is occupational organic solvent exposure a risk factor for scleroderma?. Arthritis Rheum 1998, 41:1111-1118.
19. Nietert P.J., Sutherland S.E., Silver R.M., Pandey J.P., Dosemeci M. Solvent oriented hobbies and the risk of systemic sclerosis. J Rheumatol 1999, 26:2369-2372.
20. Czirjak L., Kumanovics G. Exposure to solvents in female patients with scleroderma. Clin Rheumatol 2002, 21:114-118.
21. Czirjak L., Bokk A., Csontos G., Lorincz G., Szegedi G. Clinical findings in 61 patients with progressive systemic sclerosis. Acta Derm Venereol 1989, 69:533-536.
22. Bovenzi M., Barbone F., Betta A., Tommasini M., Versini W. Scleroderma and occupational exposure. Scand J Work Environ Health 1995, 21:289-292.
23. Garabrant D.H., Lacey J.V., Laing T.J., Gillespie B.W., Mayes M.D., Cooper B.C., et al. Scleroderma and solvent exposure among women. Am J Epidemiol 2003, 157:493-500.
24. Aryal B.K., Khuder S.A., Schaub E.A. Meta-analysis of systemic sclerosis and exposure to solvents. Am J Ind Med 2001, 40:271-274.
25. Granel B., Zemour F., Moulin P., Disdier P., Durand J.M., Gaudart J., et al. Evaluation de l'exposition toxique professionnelle de patients atteints de sclérodermie systémique Revue de la littérature et résultat d'un auto-questionnaire. Rev Med Interne 2008, 29:891-900.
26. Bradford Hill A. The environment and disease: Association or causation?. Proc Royal Soc Med 1965, 295-300.
27. Goldman J.A. Connective tissue disease in people exposed to organic solvents: systemic sclerosis (scleroderma) in dry cleaning plant and aicraft industry workers. J Clin Rheumatol 1996, 2:185-190.
28. Khan M.F., Kaphalia B.S., Prabhakar B.S., Kanz M.F., Ansari G.A. Trichloroethene-induced autoimmune response in female MRL +/+ mice. Toxicol Appl Pharmacol 1995, 134:155-160.
29. Cooper G.S., Miller F.W., Germolec D.R. Occupational exposures and autoimmune diseases. Int Immunopharmacol 2002, 2:303-313.
30. Cooper G.S., Makris S.L., Nietert P.J., Jinot J. Evidence of autoimmune-related effects of trichloroethylene exposure from studies in mice and humans. Environ Health Pers 2009, 117:696-702.